Model Informed Drug Development Archives | Page 9 of 42 | Certara

Poster

Prediction of Midazolam Concentration Profile in Obese Adolescent Population Using Physiologically Based Pharmacokinetic model

CertaraAugust 23, 2019

Poster

Prediction of Enfuvertide Concentration-Time Profile in a Paediatric Population after Parenteral Administration Using a Physiologically Based Pharmacokinetic Model

CertaraAugust 23, 2019

Poster

Simulating the effect of anti-diabetic drugs on ATP-sensitive potassium (KATP) channels inhibition in a human cardiac cell model (ORd)

CertaraAugust 23, 2019

Poster

Application of a PBPK model for prediction of the DDI between Lorazepam and Probenecid.

CertaraAugust 22, 2019

Poster

What Sample Size to Use When Designing Paediatric Pharmacokinetic Studies? A Critical Analysis of “Precision Criteria”

CertaraAugust 22, 2019

Poster

T4.1 – Setting the framework for database and development of this database

CertaraAugust 22, 2019

Poster

Modelling Toxicodynamic Feedback is Critical in Recovering Toxicokinetics in Acetaminophen Overdose

CertaraAugust 9, 2019

Poster

Development and Performance Evaluation of a semi-mechanistic PBPK Model for Topical Ocular Delivery of Pilocarpine and Timolol to Rabbit Eye

CertaraJune 24, 2019

Poster

Transporter inhibition: modelling in-vitro Transwell Assays

CertaraJune 24, 2019

White Paper

Optimize Immuno-oncology Drug Discovery and Development Using QSP

A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…

CertaraJune 19, 2019

© 2025 Certara. All Rights Reserved. | Privacy policy